The New York and Seattle-based Accelerator Corp. just expanded its fourth fund to $62.8 million to fund life sciences startups. The money comes from AbbVie, WuXi PharmaTech and Watson Fund.
Seattle’s Accelerator Corp. is expanding into New York City with $51.1 million in capital – and plans to raise more – to scout out life sciences innovators and entrepreneurs to form new biotechs based in the Big Apple. The funding comes from a number of high-profile backers, including Pfizer, Eli Lilly and Johnson & Johnson. Accelerator […]
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.